📂Shared Space

  • 🏠︎
  • Workpackages
  • Governance
  • What’s new ?
    • News
    • WP 2.1 – Natural History
    • WP 2.2 – Implementing new biomarkers for fatigue evaluation
    • WP 3.1 – Myoscreen
    • WP 4.1 – In vitro screening
    • WP 4.3 –  leads optimization for non-developable leads
  • Recruitments
  • Partners
  • Contact
  • 🏠︎
  • Workpackages
  • Governance
  • What’s new ?
    • News
    • WP 2.1 – Natural History
    • WP 2.2 – Implementing new biomarkers for fatigue evaluation
    • WP 3.1 – Myoscreen
    • WP 4.1 – In vitro screening
    • WP 4.3 –  leads optimization for non-developable leads
  • Recruitments
  • Partners
  • Contact
  • Home
  • Workpackages
  • Governance
  • What’s new ?
    • News
    • WP 2.1 – Natural History
    • WP 2.2 – Implementing new biomarkers for fatigue evaluation
    • WP 3.1 – Myoscreen
    • WP 4.1 – In vitro screening
    • WP 4.3 –  leads optimization for non-developable leads
  • Recruitments
  • Partners
  • Contact
  • Home
  • Workpackages
  • Governance
  • What’s new ?
    • News
    • WP 2.1 – Natural History
    • WP 2.2 – Implementing new biomarkers for fatigue evaluation
    • WP 3.1 – Myoscreen
    • WP 4.1 – In vitro screening
    • WP 4.3 –  leads optimization for non-developable leads
  • Recruitments
  • Partners
  • Contact

📂Shared Space

  • 🏠︎
  • Workpackages
  • Governance
  • What’s new ?
    • News
    • WP 2.1 – Natural History
    • WP 2.2 – Implementing new biomarkers for fatigue evaluation
    • WP 3.1 – Myoscreen
    • WP 4.1 – In vitro screening
    • WP 4.3 –  leads optimization for non-developable leads
  • Recruitments
  • Partners
  • Contact
  • 🏠︎
  • Workpackages
  • Governance
  • What’s new ?
    • News
    • WP 2.1 – Natural History
    • WP 2.2 – Implementing new biomarkers for fatigue evaluation
    • WP 3.1 – Myoscreen
    • WP 4.1 – In vitro screening
    • WP 4.3 –  leads optimization for non-developable leads
  • Recruitments
  • Partners
  • Contact
  • Home
  • Workpackages
  • Governance
  • What’s new ?
    • News
    • WP 2.1 – Natural History
    • WP 2.2 – Implementing new biomarkers for fatigue evaluation
    • WP 3.1 – Myoscreen
    • WP 4.1 – In vitro screening
    • WP 4.3 –  leads optimization for non-developable leads
  • Recruitments
  • Partners
  • Contact
  • Home
  • Workpackages
  • Governance
  • What’s new ?
    • News
    • WP 2.1 – Natural History
    • WP 2.2 – Implementing new biomarkers for fatigue evaluation
    • WP 3.1 – Myoscreen
    • WP 4.1 – In vitro screening
    • WP 4.3 –  leads optimization for non-developable leads
  • Recruitments
  • Partners
  • Contact

🚨 New paper published in the journal Brain!

Avatar for Ludovic PratLudovic PratJune 9, 2026
Partners of the RHU SMART consortium show that HDAC6 inhibition could represent a valuable additional SMN-independent therapeutic strategy to restore ... Read More

Congratulations to Rasha Slika 🎓✨

Avatar for Ludovic PratLudovic PratJune 9, 2026
On Thursday, April 30th, Rasha successfully defended her PhD thesis in Neuroscience entitled “Study of the Role of HDAC6 Inhibition ... Read More

Workpackages

Governance

What’s new ?

Recruitments

Partners

Contact

 

rhu-smart.fr © 2024. All rights reserved  – Legal Notice

 
HomeNewsSharedSpaceContact